A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT04965090 · COMPLETED

Trial details

NCT number: NCT04965090
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non Small Cell Lung Cancer Recurrent Non Small Cell Lung Cancer

Start date: 2021-09-30
Primary completion: 2025-12-15
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.